Summary of Study ST002001
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001269. The data can be accessed directly via it's Project DOI: 10.21228/M8PD9N This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
Study ID | ST002001 |
Study Title | A case-control study on plasma metabolomics analysis in Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) (Part 2) |
Study Summary | Targeted and untargeted metabolomics analysis consisting of 888 metabolic analytes covering primary metabolites, biogenic amines, complex lipids, and oxylipins in 106 ME/CFS cases and 91 frequency-matched healthy controls |
Institute | Columbia University |
Department | Center for Infection and Immunity |
Laboratory | Center for Infection and Immunity |
Last Name | Lipkin |
First Name | W. Ian |
Address | 722 W. 168th St., 17th Floor, New York, NY, 10032 |
wil2001@cumc.columbia.edu | |
Phone | 212-342-9033 |
Submit Date | 2021-11-22 |
Raw Data Available | Yes |
Analysis Type Detail | LC-MS |
Release Date | 2021-12-08 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
Project ID: | PR001269 |
Project DOI: | doi: 10.21228/M8PD9N |
Project Title: | Case-control study on plasma metabolomics analysis in Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) |
Project Summary: | Targeted and untargeted metabolomics analysis consisting of 888 metabolic analytes covering primary metabolites, biogenic amines, complex lipids, and oxylipins in 106 ME/CFS cases and 91 frequency-matched healthy controls. |
Institute: | Columbia University |
Department: | Center for Infection and Immunity |
Last Name: | Lipkin |
First Name: | W. Ian |
Address: | 722 W. 168th St., 17th Floor, New York, NY, 10032 |
Email: | wil2001@cumc.columbia.edu |
Phone: | 212-342-9033 |
Funding Source: | This study was funded by National Institutes of Health U54 AI138370 (Center for Solutions for ME/CFS) |
Subject:
Subject ID: | SU002082 |
Subject Type: | Human |
Subject Species: | Homo sapiens |
Taxonomy ID: | 9606 |
Gender: | Not applicable |
Factors:
Subject type: Human; Subject species: Homo sapiens (Factor headings shown in green)
mb_sample_id | local_sample_id | treatment |
---|---|---|
SA187025 | GH025_157 | case |
SA187026 | GH024_156 | case |
SA187027 | CD067_084 | case |
SA187028 | CD064_082 | case |
SA187029 | CD065_083 | case |
SA187030 | CD073_089 | case |
SA187031 | CD074_090 | case |
SA187032 | GH019_153 | case |
SA187033 | GH017_152 | case |
SA187034 | GH021_154 | case |
SA187035 | GH022_155 | case |
SA187036 | CD075_091 | case |
SA187037 | CD076_092 | case |
SA187038 | CD063_081 | case |
SA187039 | CD059_079 | case |
SA187040 | CD039_064 | case |
SA187041 | GH053_170 | case |
SA187042 | GH054_171 | case |
SA187043 | CD035_061 | case |
SA187044 | GH058_173 | case |
SA187045 | CD041_066 | case |
SA187046 | GH049_168 | case |
SA187047 | CD055_077 | case |
SA187048 | GH037_161 | case |
SA187049 | CD053_076 | case |
SA187050 | GH040_164 | case |
SA187051 | GH042_166 | case |
SA187052 | CD083_097 | case |
SA187053 | AB003_001 | case |
SA187054 | EF031_123 | case |
SA187055 | EF032_124 | case |
SA187056 | EF029_122 | case |
SA187057 | EF028_121 | case |
SA187058 | EF024_118 | case |
SA187059 | EF026_119 | case |
SA187060 | EF033_125 | case |
SA187061 | EF034_126 | case |
SA187062 | EF043_131 | case |
SA187063 | GH002-2_142 | case |
SA187064 | EF041_130 | case |
SA187065 | GH004_143 | case |
SA187066 | EF035_127 | case |
SA187067 | EF023_117 | case |
SA187068 | EF020_116 | case |
SA187069 | EF004_105 | case |
SA187070 | EF005_106 | case |
SA187071 | EF003_104 | case |
SA187072 | EF001_102 | case |
SA187073 | GH060_174 | case |
SA187074 | GH008_146 | case |
SA187075 | EF010_110 | case |
SA187076 | EF017_114 | case |
SA187077 | EF019_115 | case |
SA187078 | EF013_113 | case |
SA187079 | EF012_112 | case |
SA187080 | EF011_111 | case |
SA187081 | CD084_098 | case |
SA187082 | CD043_068 | case |
SA187083 | IJ043_189 | case |
SA187084 | AB047_026 | case |
SA187085 | IJ044_190 | case |
SA187086 | IJ046_191 | case |
SA187087 | AB037_020 | case |
SA187088 | IJ047_192 | case |
SA187089 | AB049_027 | case |
SA187090 | AB050_028 | case |
SA187091 | IJ013_184 | case |
SA187092 | IJ009_182 | case |
SA187093 | IJ014_185 | case |
SA187094 | AB055_031 | case |
SA187095 | IJ030_187 | case |
SA187096 | CD030_058 | case |
SA187097 | AB036_019 | case |
SA187098 | AB034_018 | case |
SA187099 | AB010_006 | case |
SA187100 | AB012_007 | case |
SA187101 | AB009-2_005 | case |
SA187102 | AB008_004 | case |
SA187103 | AB004_002 | case |
SA187104 | AB006_003 | case |
SA187105 | AB014_008 | case |
SA187106 | AB017_009 | case |
SA187107 | IJ052_194 | case |
SA187108 | IJ049_193 | case |
SA187109 | IJ059_195 | case |
SA187110 | AB023_011 | case |
SA187111 | AB022_010 | case |
SA187112 | IJ006_181 | case |
SA187113 | AB052_030 | case |
SA187114 | CD016_048 | case |
SA187115 | CD015_047 | case |
SA187116 | CD014_046 | case |
SA187117 | IJ001_178 | case |
SA187118 | CD001-2_038 | case |
SA187119 | CD019-2_050 | case |
SA187120 | CD027_056 | case |
SA187121 | CD024_053 | case |
SA187122 | CD022_052 | case |
SA187123 | CD020_051 | case |
SA187124 | CD011_044 | case |
Collection:
Collection ID: | CO002075 |
Collection Summary: | Plasma was collected and frozen at -80. |
Sample Type: | Blood (serum) |
Treatment:
Treatment ID: | TR002094 |
Treatment Summary: | Blinded study of control versus cases. |
Sample Preparation:
Sampleprep ID: | SP002088 |
Sampleprep Summary: | 1 Thaw plasma samples on ice 2 Vortex plasma sample and pipette 50µl in polypropylene Eppendorf tube/Plate 3 Add Surrogate Standards of the 3 lipid classes (as needed) and other reagents as in the following table: Plasma Sample 10x Oxylipid Surrogate STDs CUDA + PHAU Anti-oxidant ACN/MeOH SUM 4 Vortex for 30sec 5 Centrifuge at 6°C for 5 min at 15,000 g (or 1,800 g for plates) 6 Take the supernatant (~240µl) into new Eppendorf tube/filter plate 7 Spin Filter (0.1 um) or plate filter (0.2um) for 5 min @ 12,000 g (1,800g for plate) 8 place aliquotes of samples into vials, or plate, and cap vials or seal plates 9 Store in -20°C until analysis |
Combined analysis:
Analysis ID | AN003264 |
---|---|
Analysis type | MS |
Chromatography type | HILIC |
Chromatography system | Thermo Vanquish |
Column | Waters Acquity BEH Amide (150 x 2.1mm,1.7um) |
MS Type | ESI |
MS instrument type | Triple quadrupole |
MS instrument name | ABI Sciex 4000 QTrap |
Ion Mode | UNSPECIFIED |
Units | nM |
Chromatography:
Chromatography ID: | CH002408 |
Chromatography Summary: | Targeted oxylipin analysis |
Instrument Name: | Thermo Vanquish |
Column Name: | Waters Acquity BEH Amide (150 x 2.1mm,1.7um) |
Chromatography Type: | HILIC |
MS:
MS ID: | MS003036 |
Analysis ID: | AN003264 |
Instrument Name: | ABI Sciex 4000 QTrap |
Instrument Type: | Triple quadrupole |
MS Type: | ESI |
MS Comments: | analyzed by a Waters UPLC with a 2.1×150 mm, 1.7 µm Acquity BEH column, ESI (+) and (-) switching and detection by multi-reaction monitoring on an Sciex 6500+ QTRAP mass spectrometer. We validated this method for linearity, limit of detection, limit of quantitation, inter- and intra-day reproducibility, and recovery for all targets, yielding better than 15% relative standard deviation and (spiked) recoveries of greater than 80%. |
Ion Mode: | UNSPECIFIED |